Active, not recruitingPhase 3NCT04440189

Autologous Adipose-derived Stromal Vascular Fraction for Treatment of Knee Osteoarthritis

Studying Microphthalmia with limb anomalies

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
GID BIO, Inc.
Principal Investigator
William Cimino, PhD
GID BIO
Intervention
GID SVF-2 Device System(device)
Enrollment
114 target
Eligibility
35-85 years · All sexes
Timeline
20202025

Study locations (9)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04440189 on ClinicalTrials.gov

Other trials for Microphthalmia with limb anomalies

Additional recruiting or active studies for the same condition.

See all trials for Microphthalmia with limb anomalies

← Back to all trials